BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence. Founded by Mark DePristo, Peyton Greenside, and Theresa Tribble in 2019, BigHat Biosciences is backed by investors that include Andreessen Horowitz, 8VC, AME Cloud Ventures, and Innovation Endeavors and is headquartered in San Carlos.